Tatyana A. Platonova

Tatyana A. Platonova

Auto-generated profile, based on publicly available information

Tatyana A. Platonova

Ural State Medical University, Ekaterinburg; European Medical Center “UMMC-Health”; Federal Research Institute of Viral Infections “Virom” of Rospotrebnadzor

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2021 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
TPT. A. Platonova
T. A. Platonova
AGA. A. Golubkova
A. A. Golubkova
ATA. V. Tutelyan
A. V. Tutelyan
Svetlana S. SmirnovaSvetlana S. Smirnova
Svetlana S. Smirnova
Relevance. During the pandemic of the new coronavirus infection (COVID-19), one of the most vulnerable and actively involved in the epidemic process categories of the population were medical workers. The study of the incidence of COVID-19 among medical workers, risk factors for infection and safety measures is an important area of research in modern conditions. The aim of the study is to assess the prevalence of COVID-19 among employees of medical organizations and occupational risk factors for infection in order to develop proposals for corrective measures. Materials and methods. To study the incidence of COVID-19 among employees of medical organizations, an anonymous online questionnaire developed by the authors was used, which was posted on the Google platform and distributed during the first wave of the pandemic among employees of medical organizations in several regions of the Russian Federation through corporate e-mail or specialized online resources adapted for health workers. The survey involved 1,872 medical workers of different genders, ages, positions and work experience. Results and discussion. Among the survey participants, 161 employees have already had a new coronavirus infection. In the majority (64.0%) of them, the disease occurred in the form of acute respiratory infection, in 28.6% - interstitial pneumonia, in 7.4% only the fact of isolation of the SARSCoV-2 antigen without clinical manifestations of infection was documented. The most affected contingents were secondary and junior medical personnel, mainly hospital staff. The likelihood of infection in the workplace was increased by factors such as providing care to patients with confirmed COVID-19, participating in procedures related to aerosol generation, working with biomaterials of patients with COVID-19, contact with surfaces in the environment of a COVID-19 patient, ignorance of infectious safety issues due to lack of instruction before admission to work. When assessing the efficiency of personal protective equipment (PPE) when they are used in the process, it was found that the highest value for the prevention of infection COVID-19 had a PPE for face protection, respiratory and eye, and hand hygiene. At the same time, many employees are faced with the problem of an insufficient number of protective equipment in the workplace. When assessing the availability of SARS-CoV-2 testing to employees, it was found that only 77.4% of survey participants had the opportunity to be tested for coronavirus infection in a timely manner. Conclusion. Thus, for more effective protection of employees of medical organizations, it is necessary to have a sufficient number of personal protective equipment, especially for the face, respiratory organs and vision, the availability of hygienic hand treatment during work, regular instruction on infectious safety, using interactive forms of training, and the organization of screening examinations of previously unvaccinated and unvaccinated employees.

15 March 2022 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
TPT A Platonova
T A Platonova
AGA A Golubkova
A A Golubkova
MSM S Sklyar
M S Sklyar
EKE A Karbovnichaya
E A Karbovnichaya
Svetlana S. SmirnovaSvetlana S. Smirnova
Svetlana S. Smirnova
К вопросу оценки эффективности вакцинации сотрудников медицинских организаций против COVID-19

1 May 2019 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
TPT. A. Platonova
T. A. Platonova
AGA. A. Golubkova
A. A. Golubkova
EKE. S. Koltunova
E. S. Koltunova
SSS. S. Smirnova
S. S. Smirnova
VAV. V. Abdulvalieva
V. V. Abdulvalieva
OKO. A. Kuznezova
O. A. Kuznezova
Национальный календарь профилактических прививок: качество исполнения и определяющие факторы

1 January 2023 in Infectious diseases: News, Opinions, Training
Verified
Journal Article
Open access
TPT.A. Platonova
T.A. Platonova
AGA.A. Golubkova
A.A. Golubkova
Svetlana S. SmirnovaSvetlana S. Smirnova
Svetlana S. Smirnova
YRYekaterinburg Fsrivi Virome Rospotrebnadzor
Yekaterinburg Fsrivi Virome Rospotrebnadzor
VMV.а. Mishchenko
V.а. Mishchenko
ASAleksandr Vladimirovich Semenov
Aleksandr Vladimirovich Semenov
Эпидемический процесс COVID-19 в Российской Федерации: детерминанты и проявления

13 March 2021 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
ТПТ. А. Платонова
Т. А. Платонова
АГА. А. Голубкова
А. А. Голубкова
EKE. A. Karbovnichaya
E. A. Karbovnichaya
Svetlana S. SmirnovaSvetlana S. Smirnova
Svetlana S. Smirnova
Relevance In the context of the new coronavirus infection (COVID-19) pandemic, research on the formation of an immune response to SARS-CoV-2 in patients with various clinical forms of this infection is of particular relevance, which is important for understanding the degree of their participation in the formation of population immunity and assessing individual immunity to SARS-CoV-2 in the future. Aim of the study was to analyze the timing of the formation of specific antibodies to SARS-CoV-2 and the duration of their preservation in patients with a new coronavirus infection. Materials and methods. The timing of the formation of specific antibodies of three classes (IgA, IgM and IgG) to SARS-CoV-2 in 218 patients was evaluated in the first days of the disease. Subsequently, they were re-examined at various times from the onset of the disease, from one to four times (a total of 321 control points). To assess the duration of preservation of antibodies to COVID-19 in patients who were ill, a prospective study was organized, in which 368 people participated. Screening for specific class G antibodies was performed every 2–4 weeks, within one to eight months of the onset of clinical manifestations of COVID-19. In total 919 control points. The antibodies were examined by solid-phase enzyme immunoassay using the SARS-CoV-2IgM-ELISA-BEST and SARS-CoV-2-IgG-ELISA-BEST test systems (manufactured by VECTOR-BEST JSC) and Antigma A (manufactured by Generium). Results. In most of the examined individuals, class M and G antibodies began to form from day 10 of the disease, while class A antibodies were detected from day 5. In mild and asymptomatic forms of coronavirus infection, IgG antibodies to SARS-CoV-2 were not formed in most cases, and seroprotection levels correlated with the severity of the disease. The duration of preservation of IgG antibodies could be at least 8 months, but there were isolated cases of their elimination both after COVID-19 in the form of respiratory infection and after interstitial pneumonia. With continuing problems with COVID-19, there were no cases of recurrent disease among individuals who formed G-antibodies (including those who lost them 4-5 months after the disease) during the follow-up period. Conclusion. Thus, according to the results of the study, important materials were obtained on the peculiarities of the formation of a humoral immune response to a new coronavirus infection. However, to fully understand the immune response to SARS-CoV-2, it is necessary to assess the avidity of IgG antibodies or their ability to neutralizing the virus, as well as to study cellular immunity in patients who have had COVID-19 but have not formed antibodies.

22 June 2022 in Pacific Medical Journal
Verified
Journal Article
Open access
PDF file
TPT. A. Platonova
T. A. Platonova
AGA. A. Golubkova
A. A. Golubkova
MSM. S. Sklyar
M. S. Sklyar
Svetlana S. SmirnovaSvetlana S. Smirnova
Svetlana S. Smirnova
EKE. A. Karbovnichaya
E. A. Karbovnichaya
ANA. D. Nikitskaya
A. D. Nikitskaya
Objective: The aim of the study was to assess non-professional risk factors for COVID-19 infection in medical workers and predictors of the development of severe clinical forms of the disease.Methods: The authors developed two online questionnaires to analyze the features of the clinical manifestations of COVID-19 and the impact of various risk factors on the employees of the Ministry of Defense. Questionnaires were filled out by 366 medical workers who had previously had a new coronavirus infection, and 306 employees who were intact for this disease.Results: When assessing the risk factors for SARS-CoV-2 infection, it was found that factors such as irregular preventive intake of vitamin D and multivitamins increased the risk of infection of employees of the Ministry of Defense by 1.5-2 times. The majority of employees (281 or 76.8%) suffered the disease in the form of acute respiratory infection (ARI) of mild or moderate severity, 23.2% (85 people) had a lesion of the pulmonary parenchyma in the form of interstitial pneumonia. The most severe clinical forms of COVID-19 occurred in employees in the age group older than 40 years, with a body mass index corresponding to overweight (more than 25.0), having chronic diseases of the genitourinary system, diabetes mellitus, and low physical activity.Conclusions: According to the results of the conducted study, the main clinical manifestations of the new coronavirus infection among medical workers, their severity in various forms of the disease, the leading non-professional risk factors for infection and predictors of the development of more severe clinical forms of COVID-19 were determined.